192 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
2 Feb 12
Other Events
12:00am
with a simplified alternative to current practices. According to national health statistics and market assessment data, it is estimated that each year … requiring ventilatory support. According to national health statistics and market assessment data, it is estimated that each year more than 1.3 million
8-K
EX-99.2
WINT
Windtree Therapeutics Inc
8 May 08
Discovery Labs Reports First Quarter 2008 Financial Results
12:00am
performed an assessment of the remaining conditions set forth in the Approvable Letter that must be satisfied to gain U.S. marketing approval for Surfaxin … and operations of Discovery Labs were inspected by the FDA with acceptable results.
May 1st Approvable Letter
Discovery Labs has completed an assessment
8-K
WINT
Windtree Therapeutics Inc
19 Dec 01
Other events
12:00am
of three milestones. One-third of the commitment will be available upon the
later to occur of (i) the completion of a market opportunity assessment … by Quintiles of a
favorable written assessment and report regarding such data and Discovery
("Milestone Two").
Provided that Milestone One
8-K
EX-99.2
WINT
Windtree Therapeutics Inc
24 Oct 12
Other Events
12:00am
the Market for SURFAXIN® Neonatologists (A)(n=105) Pharmacy Directors (B)(n=51) Data on file, Discovery Laboratories, Inc. 2012* Baseline assessment … Assessment of Interest and Likelihood to Advocate for SURFAXIN on NICU Formulary*
* SURFAXIN® NICU Market Economics & Pricing Uncomplicated U.S
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
29 Jul 11
Other Events
12:00am
intermittent mechanical ventilation or continuous positive airway pressure. According to national health statistics and market assessment data recently … the AFECTAIR product line in both markets in 2012.
“We have completed and are encouraged by our comprehensive assessment of the operational, regulatory
S-8
EX-23.2
54qrsie1i
12 Dec 07
Registration of securities for employees
12:00am
8-K
EX-99.1
1d5lldjn2m0w d5g
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
4cd47xt
16 Feb 10
Other Events
12:00am
8-K
k4h 772muf
11 May 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
x1xpplo6j9g0pg29kb
18 Apr 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-10.4
ncerfg49uqtojd9oxnsi
19 Dec 01
Other events
12:00am
8-K/A
EX-10.4
6cgcubqu11cynlah
14 Jan 02
Other events
12:00am
S-8
EX-23.2
rz3tmq9lsmaqpa
23 Aug 05
Registration of securities for employees
12:00am
S-8
EX-23.2
2i9ldp
7 Nov 06
Registration of securities for employees
12:00am
8-K
EX-99.1
xfdsiswqbn
5 Aug 04
Results of Operations and Financial Condition
12:00am
S-8
EX-23.2
cded9bagf1quipnrhc22
28 Sep 06
Registration of securities for employees
12:00am